Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Exercise Intensity for Vascular Health in Metabolic Syndrome
NCT03355469Phase 3Completed
- Sponsor
- Rutgers University
- Start
- Aug 2017
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in metabolic syndrome, sponsored by Rutgers University. Started Aug 2017; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT03355469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03355469.